Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein. ##STR00001## wherein A is an optionally substituted aryl or an optionally substituted heteroaryl; B is an optionally substituted aryl or an optionally substituted heteroaryl; R.sup.1 is hydrogen, (C.sub.1 C.sub.4)alkyl, halo-substituted (C.sub.1 C.sub.4)alkyl, or (C.sub.1 C.sub.4)alkoxy; and R.sup.4 is as described herein.

 
Web www.patentalert.com

< Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives

< Compounds and methods for modulating nonclassical cadherin-mediated functions

> Method of preparing amine stereoisomers

> Proteins and nucleic acids encoding same
~ 00299